JPS5328788U - - Google Patents
Info
- Publication number
- JPS5328788U JPS5328788U JP11047976U JP11047976U JPS5328788U JP S5328788 U JPS5328788 U JP S5328788U JP 11047976 U JP11047976 U JP 11047976U JP 11047976 U JP11047976 U JP 11047976U JP S5328788 U JPS5328788 U JP S5328788U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11047976U JPS5328788U (de) | 1976-08-18 | 1976-08-18 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11047976U JPS5328788U (de) | 1976-08-18 | 1976-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5328788U true JPS5328788U (de) | 1978-03-11 |
Family
ID=28720355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11047976U Pending JPS5328788U (de) | 1976-08-18 | 1976-08-18 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5328788U (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11992551B2 (en) | 2014-05-29 | 2024-05-28 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US12186237B2 (en) | 2006-11-10 | 2025-01-07 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
-
1976
- 1976-08-18 JP JP11047976U patent/JPS5328788U/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12186237B2 (en) | 2006-11-10 | 2025-01-07 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US11992551B2 (en) | 2014-05-29 | 2024-05-28 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |